Stay updated on Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial
Sign up to get notified when there's something new on the Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial page.

Latest updates to the Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision: v3.4.2 is now shown and the government funding/status notice has been removed, reflecting administrative updates that do not affect study content. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check21 days agoChange DetectedA site-wide notice about a lapse in government funding and NIH Clinical Center operating status was added, with links to cc.nih.gov and opm.gov. A new site revision tag v3.4.1 was introduced (replacing v3.4.0).SummaryDifference0.4%

- Check28 days agoChange DetectedAdded a glossary toggle and updated QC-related labels (Last Update Submitted that Met QC Criteria; Revision: v3.4.0), plus minor capitalization changes.SummaryDifference0.2%

- Check64 days agoChange DetectedAdded a Locations section listing District of Columbia, North Carolina, and Pennsylvania sites and updated to Revision: v3.3.3. Removed the previous standalone District of Columbia, North Carolina, and Pennsylvania location entries.SummaryDifference0.4%

- Check85 days agoChange Detected- Revision updated from v3.3.1 to v3.3.2. The update does not modify study details, eligibility criteria, or reported results.SummaryDifference0.1%

- Check93 days agoChange DetectedThe site revision updated from v3.2.0 to v3.3.1, a metadata change that does not affect study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Cyclophosphamide+Pembrolizumab in Metastatic TNBC Clinical Trial page.